| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05824871 | A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary… | Rifampin-Resistant Pulmonary Tuberculosis | Recruiting |
| NCT07392060 | A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's… | Cervical Cancer Metastatic | Not Yet Recruiting |
| Phase 2 | |||
| NCT06117540 | A Study of WX390 in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting |
| NCT06124963 | A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type… | Gastric Type Adenocarcinoma (GAS) With STK11 Mutation | Recruiting |
| Phase 1/2 | |||
| NCT06117566 | A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors | Solid Tumor | Recruiting |
| Phase 1 | |||
| NCT06701110 | Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects | TB | Recruiting |
| NCT06701136 | Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and… | Rifampicin-Resistant Pulmonary Tuberculosis Patients | Not Yet Recruiting |